Pharm Exec

FDA Grants Emergency Use Authorization for Seegene’s Multiplex PCR Assay

FDA has granted Emergency Use Authorization to Seegene USA's Allplex multiplex PCR assay, making it the first U.S.-authorized test to simultaneously detect and differentiate HSV-1, HSV-2, VZV, and ...
Pharm Exec

All News

In today's Pharmaceutical Executive Daily, FDA grants emergency use authorization for Seegene's multiplex PCR assay, a Pfizer medical lead makes the case for continued antiviral use among Covid-19 ...
PharmExec

How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control ...

Gerren McHam, vice president of Government and External Affairs, API Innovation Center, describes how China’s recent export control updates may introduce new vulnerabilities for ...
Pharm Exec

FDA Clears Consano’s IND for C-1101

FDA IND clearance enables U.S. site activation for the ongoing Phase I C-1101-101 trial, with initial dosing already completed in Australia and near-term plans to begin treating U.S. patients. C-1101 ...
PharmExec

Hiring and Fostering Top Talent

David Hung, president, CEO, and founder of Nuvation Bio, discusses his leadership style, emphasizing the importance of hiring ...
PharmExec

Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D

Viral surveillance and predictive modeling are used to map mutational escape pathways and inform proactive antibody design against likely future variants rather than only current circulating strains.
PharmExec

FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia

Indication includes adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia, for LDL-C ...
Pharm Exec

Editorial Podcasts

In today's Pharmaceutical Executive Daily, FDA approves Merck's Lipfendra as the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly agrees to acquire AtaiBeckley for up to $3.8 billion, and a ...
Pharm Exec

Arthur G. Cook

Arthur G. Cook is Principal, ZS Associates.
Pharm Exec

Pharmaceutical Executive

Pharmaceutical Executive | Publications | Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.
Pharm Exec

Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement

Kp-104 (vensobafusp alfa) advances as a Phase II/III-ready bifunctional complement biologic targeting alternative and terminal pathways, with rare renal Phase II basket interim reads in Q4 2026 and Q2 ...
Pharm Exec

Jim Kalustian

Jim Kalustian | Authors | Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.